Corporate Sponsors

AIRA Matrix provides Artificial Intelligence solutions for Clinical and  Life Sciences applications. Our products and services improve efficiency, diagnostic accuracy, and turn around times in pathology laboratory workflows. Our diagnostic, prognostic, and predictive solutions for cancer care aid disease stratification and enable management protocols tailored to improve treatment outcomes.

Clinisys is a global provider of intelligent diagnostic informatics solutions and expertise designed to redefine the modern laboratory, across healthcare, life sciences and public health. Millions of diagnostic results and data insights are generated every day using Clinisys’ platform and cloud-based solutions in over 3,000 laboratories across 34 countries. Headquartered in Tucson, Arizona and Chertsey, England, Clinisys’ mission is to enhance the effectiveness of diagnostic workflows in any laboratory or testing environment and keep citizens and communities healthier and safer. To learn more visit www.clinisys.com.

Hamamatsu Photonics products and technology include optical sensors, light sources, and systems that use these components. They are applied to various new technologies and devices to support people’s lives and to help achieve a more comfortable and prosperous society. For example, our products are widely used for state-of-the-art medical equipment, test and inspection systems, microscopes that reveal the functions of cells, and giant telescopes that explore the mysteries of the universe.

Ibex is the pioneer in applying computational pathology to cancer diagnostics. Based out of Tel Aviv, Israel, the company's machine learning experts, data scientists and pathologists use artificial intelligence (AI) to develop clinical grade algorithms that can detect prostate cancer as accurately as a human pathologist.

Pathologists are challenged to provide accurate and timely analysis as the number of tests increases year-over-year.  In an effort to improve their workflow, pathology labs are starting to adopt digital technologies, including AI-based analysis of biopsies.  Ibex's algorithms analyzes biopsy images, detects cancerous cells, grades them and can also detect other clinically significant features.  The analysis is presented to pathologists either before or after reviewing the case, helping them in reducing error rates and improving operational efficiency by reducing the average time spent on a case.

Deployed in Israel, Europe and the United States, Ibex's solution is the first-ever AI-based cancer diagnosis solution in routine clinical use in a pathology lab and has already demonstrated success in detecting missed cancer cases.  The first application Ibex released is for prostate and breast and it works on expanding to additional tissues.  Ibex recently raised $15 million from prominent VC funds and corporate investors.

Whether you need a routine checkup or heart valve replacement, our doctors help you reach and maintain your optimal health, while providing the highest standard of care and the most advanced treatment options.

We have the expertise and provide the full range of patient care and services to meet all your healthcare needs. Specialists at Perlmutter Cancer Center offer the latest advances in cancer treatment. Care for children is provided through Hassenfeld Children’s Hospital at NYU Langone.

PhenoPath, a Quest Diagnostics® company, helps you see a clearer path forward for the diagnosis, treatment, and prognosis of your cancer patients. Built on a foundation of academic and medical excellence, PhenoPath pathologists will work with you to bring new insights to your most difficult cases. Some of the specialized services we offer include PD-L1 interpretation, flow cytometry (10-color), FISH, PCR, cytogenetics, and special stains. PhenoPath is here for you when you need a diagnosis you can count on.

Gestalt transforms pathology through an intelligent, configurable, and vendor-neutral digital workflow that provides true interoperability enabling pathologists to diagnose diseases faster and more efficiently. Our PathFlow® solution is a cloud-based digital pathology enterprise platform that can easily be customized based on your specific preferences. This platform consists of professional, education, and research modules for ease of mixing and matching the digital needs of your facility in a single solution, freeing pathologists from tedious, repetitive, and manual tasks allowing them to focus on their expertise, providing their invaluable experience where it matters most.

Scopio Labs, developer of the only Full-Field Cell Morphology™ imaging and analysis platform, provides end-to-end digital workflow solutions to revolutionize the hematology field and bring it into the digital age. Through advanced imaging and powerful AI technology, Scopio is making manual microscopy obsolete. Scopio’s solutions enhance diagnostic clinical workflows and allow cross-laboratory collaboration to standardize diagnostic testing and ultimately improve patient outcomes.